G90.B ICD-10-CM Code: LMNB1-related autosomal dominant leukodystrophy
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Diseases of the nervous system (G00-G99) / Other disorders of the nervous system (G89-G99)
G90.B
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceLMNB1-related autosomal dominant leukodystrophy
LMNB1-related autosomal dominant leukodystrophy is a rare genetic disorder affecting the white matter of the brain, caused by mutations in the LMNB1 gene.

Buddy Insight
LMNB1-related autosomal dominant leukodystrophy is a rare inherited white matter disease caused by duplication of the LMNB1 gene, leading to progressive demyelination of the central nervous system.
CMS-HCC V28
MappedHCC 200
RAF 0.262
CMS-HCC V24
00
RAF 0
ACA/HHS
00
RAF 0
ESRD/PACE
00
RAF 0
RXHCC
00
RAF 0
Code Trumping
Basket needed
Code Book Path
Inclusion Terms
OfficialICD-10-CM does not list inclusion terms for G90.B in this effective period.
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for G90.B in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for G90.B in this effective period.
Excludes 1
Official- dysfunction of the autonomic nervous system due to alcohol (G31.2)
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for G90.B in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for G90.B in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for G90.B in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.
Is G90.B an HCC code?
Yes. G90.B maps to Cerebellar Ataxia and Other Degenerative Diseases of Nervous System under the CMS-HCC V28 risk adjustment model.
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for G90.B
For G90.Bto count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed G90.B during that encounter, not just copy-forwarded from a problem list.
What This Code Means
G90.B is the ICD-10-CM diagnosis code for lmnb1-related autosomal dominant leukodystrophy. LMNB1-related autosomal dominant leukodystrophy is a rare genetic disorder affecting the white matter of the brain, caused by mutations in the LMNB1 gene. G90.B sits in the ICD-10-CM chapter for diseases of the nervous system (g00-g99), within the section covering other disorders of the nervous system (g89-g99).
Under the CMS-HCC V28 risk adjustment model, G90.B maps to Cerebellar Ataxia and Other Degenerative Diseases of Nervous System (HCC 200) with a community, non-dual, aged base RAF weight of 0.262. G90.B was not retained as a payment HCC under the older V24 model, so V28 introduced or recategorized it during the 2024–2026 phase-in. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Genetic testing confirmation should be documented in the medical record. Because G90.B maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for G90.B sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Genetic testing confirmation should be documented in the medical record
- •This is a rare disease; ensure genetic counseling and specialized neurology involvement is documented
Clinical Significance
LMNB1-related autosomal dominant leukodystrophy is a rare inherited white matter disease caused by duplication of the LMNB1 gene, leading to progressive demyelination of the central nervous system. It typically presents in the fourth or fifth decade of life with autonomic dysfunction, cerebellar ataxia, and pyramidal signs. This is a significant risk adjustment code given the progressive neurological deterioration and high care needs.
Documentation Requirements
- ✓Genetic testing confirming LMNB1 gene duplication
- ✓MRI findings demonstrating progressive white matter changes consistent with leukodystrophy
- ✓Neurological examination documenting pyramidal signs, cerebellar dysfunction, and autonomic abnormalities
- ✓Family history of autosomal dominant inheritance pattern
- ✓Current functional status and neurological progression documentation
Commonly Confused Codes
- •G93.44: Adult-onset leukodystrophy with axonal spheroids: different genetic basis (CSF1R gene), different pathology
- •G93.42: Megalencephalic leukoencephalopathy with subcortical cysts: typically childhood onset, different genetic cause
- •G35: Multiple sclerosis: acquired demyelinating disease with relapsing-remitting pattern, not hereditary
- •E75.25: Metachromatic leukodystrophy: different enzyme deficiency (arylsulfatase A), different inheritance pattern